Last reviewed · How we verify

NCT04290078: BACKSPIN

The Kaia Back Pain Intervention for Self-management of Low Back Pain

Status unknown NA Last updated 8 December 2020
What this trial tests

NA trial testing Kaia Back Pain Study App in Low Back Pain in 184 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
1 June 2021
1 August 2021

Quick facts

Lead sponsorKaia Health Software
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment184
Start date1 December 2020
Primary completion1 June 2021
Estimated completion1 August 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kaia Health Software

Who can join

Adults 21 to 75, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate outcomes of the use of Kaia Study app (software program application for self-management of low-back pain) on back pain among adults with non-specific subacute and chronic low back pain based on change in pain intensity, physical functioning, quality of life (PROMIS-10) based on self-reported information from baseline to study end as compared to a control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Kaia Health Software trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04290078.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing